Cardiff Oncology Inc (FRA:XE7C)
€ 2.8 0.1 (3.7%) Market Cap: 150.33 Mil Enterprise Value: 95.75 Mil PE Ratio: 0 PB Ratio: 3.01 GF Score: 59/100

Cardiff Oncology Inc to Provide a Clinical and Corporate Update Call Transcript

Sep 12, 2022 / 08:30PM GMT
Release Date Price: €2.93 (+4.01%)
Operator

Greetings, and welcome to the Cardiff Oncology Clinical and Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn this conference over to your host, Mr. Tom Galassi of LifeSci Advisors. Thank you, sir. You may begin.

Thomas Galassi
LifeSci Advisors, LLC - MD of Investor Communications

Thank you, operator, and thank you all for participating in today's call. Before we start, I would like to point out that the slides referenced by management on today's call will be broadcast on the webcast system. For those of you who have dialed in by phone, you can download the webcast slides from the Cardiff Oncology homepage.

I'd also like to remind everyone listening that certain statements in this presentation are forward-looking within the meaning of the Private Litigation Reform Act of 1995 as is closed on the slide. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. and investors should

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot